Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Payables (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Payables for 3 consecutive years, with $182000.0 as the latest value for Q4 2025.

  • Quarterly Payables fell 84.96% to $182000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $182000.0 through Dec 2025, down 84.96% year-over-year, with the annual reading at $182000.0 for FY2025, 84.96% down from the prior year.
  • Payables hit $182000.0 in Q4 2025 for Camp4 Therapeutics, down from $585000.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $3.9 million in Q3 2024 to a low of $182000.0 in Q4 2025.
  • Historically, Payables has averaged $1.4 million across 3 years, with a median of $1.2 million in 2025.
  • Biggest five-year swings in Payables: rose 16.12% in 2024 and later tumbled 84.96% in 2025.
  • Year by year, Payables stood at $1.0 million in 2023, then increased by 16.12% to $1.2 million in 2024, then crashed by 84.96% to $182000.0 in 2025.
  • Business Quant data shows Payables for CAMP at $182000.0 in Q4 2025, $585000.0 in Q3 2025, and $1.2 million in Q2 2025.